Clinical Trials Directory

Trials / Conditions / Primary Peritoneal Transitional Cell Carcinoma

Primary Peritoneal Transitional Cell Carcinoma

7 registered clinical trials studyying Primary Peritoneal Transitional Cell Carcinoma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingMinimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary
NCT04575935
M.D. Anderson Cancer CenterPhase 3
Active Not RecruitingA Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With
NCT04092270
National Cancer Institute (NCI)Phase 1
TerminatedThe Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors
NCT03641287
University of WashingtonN/A
TerminatedMV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cance
NCT02364713
Mayo ClinicPhase 2
CompletedNab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cance
NCT02020707
Mayo ClinicPhase 1
CompletedBevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epi
NCT00951496
National Cancer Institute (NCI)Phase 3
Active Not RecruitingCarboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Pa
NCT00565851
National Cancer Institute (NCI)Phase 3